Clinical Trials Directory

Trials / Completed

CompletedNCT04016285

Total Knee Replacement With Tourniquet or Aquamantys

Comparison to Short-duration Tourniquet Total Knee Arthroplasty (TKA) With the Aquamantys® Bipolar Sealer and the Standard of Care in the Setting of Outpatient TKA: A Randomized, Double-blinded Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
73 (actual)
Sponsor
Stephen Duncan · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare quadriceps muscle strength, pain, opioid consumption and patient function during the first three months after short-stay total knee replacement between patients treated with short-duration tourniquet knee replacement with the Aquamantys® bipolar sealer versus those treated with the standard of care (tourniquet used throughout the case and no Aquamantys®). By doing this study, investigators hope to learn if short duration tourniquet knee replacement with the Aquamantys® bipolar sealer is more effective than standard of care (tourniquet used throughout the case and no Aquamantys®). The purpose of this study is to compare quadriceps muscle strength, pain, opioid consumption and patient function during the first three months after short-stay total knee replacement between patients treated with short-duration tourniquet knee replacement with the Aquamantys® bipolar sealer versus those treated with the standard of care (tourniquet used throughout the case and no Aquamantys®).

Conditions

Interventions

TypeNameDescription
DEVICEAquamantysThe Aquamantys bipolar sealer is a device used during surgery to help reduce bleeding in the joint. The system uses radiofrequency energy and sterile saline (salt water) to close small blood vessels in the knee to help reduce bleeding.
DEVICETourniquetStandard of care for reducing bleeding during the total knee arthroplasty

Timeline

Start date
2019-01-15
Primary completion
2023-02-07
Completion
2023-04-18
First posted
2019-07-11
Last updated
2024-04-18
Results posted
2024-04-18

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04016285. Inclusion in this directory is not an endorsement.